Tapewire

NYSE · USD

ACH

ACCENDRA HEALTH INC/VA/

Export transactions ↓
Tapewire entity
6858
SEC CIK
0000075252
Parsed reports
707

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2023 Filed Mar 3, 2023 12:59 UTC GrantCommon Stock 32,384 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005696 · form4.xml · nonDerivative · entry 1

Bruni Alexander J · CIK 0001949360 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,313

F1 · security: Restricted stock grant which vests one-third per year over three years.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 12:59 UTC
Bernocchi Perry AEVP, CEO,. Patient Direct
GrantCommon Stock 35,150 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005695 · form4.xml · nonDerivative · entry 2

Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,676

F2 · security: Restricted stock which vests on March 15, 2024.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 12:59 UTC
Bernocchi Perry AEVP, CEO,. Patient Direct
GrantCommon Stock 64,767 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005695 · form4.xml · nonDerivative · entry 1

Bernocchi Perry A · CIK 0001967402 · EVP, CEO,. Patient Direct

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,526

F1 · security: Restricted stock grant which vests one-third per year over three years.

Read SEC document
December 30, 2022 Filed Jan 4, 2023 21:33 UTC
Pesicka Edward ADirector · President & CEO
GrantCommon Stock 32 $16.52 $528.77
Disclosure

SEC source: 0001062993-23-000313 · form4.xml · nonDerivative · entry 1

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,283,732

F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).

Read SEC document
December 30, 2022 Filed Jan 4, 2023 21:33 UTC
Pace Nicholas JEVP, General Counsel
GrantCommon Stock 32 $16.52 $528.77
Disclosure

SEC source: 0001062993-23-000311 · form4.xml · nonDerivative · entry 1

Pace Nicholas J · CIK 0001497051 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,857

F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).

Read SEC document
December 30, 2022 Filed Jan 4, 2023 21:33 UTC
Lowry Michael WayneSVP, Corporate Controller
GrantCommon Stock 726 $16.52 $11,996.42
Disclosure

SEC source: 0001062993-23-000308 · form4.xml · nonDerivative · entry 1

Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,077

F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).

Read SEC document
December 01, 2022 Filed Dec 2, 2022 22:15 UTC GrantPhantom Stock · Derivative 460 $20.40 $9,384.00
Disclosure

SEC source: 0001062993-22-023242 · form4.xml · derivative · entry 1

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,074

Underlying: Common Stock · 460 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
November 15, 2022 Filed Nov 17, 2022 13:33 UTC
Sarkar SnehashishChief Information Officer
GrantCommon Stock 9,853 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-022347 · form4.xml · nonDerivative · entry 1

Sarkar Snehashish · CIK 0001951379 · Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,853

F1 · security: Restricted stock grant which vests one-third per year over three years.

Read SEC document
November 14, 2022 Filed Nov 15, 2022 22:45 UTC
Leon Jonathan ASVP, Corporate Treasurer
Tax withholdingCommon Stock 725 $21.22 $15,384.50
Disclosure

SEC source: 0001062993-22-022225 · form4.xml · nonDerivative · entry 1

Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,128

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
November 11, 2022 Filed Nov 14, 2022 22:01 UTC
Long Andrew GEVP, CEO P&HS
Tax withholdingCommon Stock 7,442 $21.29 $158,440.18
Disclosure

SEC source: 0001062993-22-022096 · form4.xml · nonDerivative · entry 1

Long Andrew G · CIK 0001714880 · EVP, CEO P&HS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,409

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
October 27, 2022 Filed Oct 31, 2022 21:24 UTC
Leon Jonathan ASVP, Corporate Treasurer
Tax withholdingCommon Stock 584 $17.21 $10,050.64
Disclosure

SEC source: 0001062993-22-021286 · form4.xml · nonDerivative · entry 1

Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,853

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
October 17, 2022 Filed Oct 18, 2022 20:23 UTC PurchaseCommon Stock 1,000 $15.68 $15,680.00
Disclosure

SEC source: 0001062993-22-020909 · form4.xml · nonDerivative · entry 1

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,000

F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020.

Read SEC document
September 01, 2022 Filed Sep 2, 2022 13:32 UTC GrantPhantom Stock · Derivative 337 $27.85 $9,385.45
Disclosure

SEC source: 0001062993-22-019054 · form4.xml · derivative · entry 1

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,614

Underlying: Common Stock · 337 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
July 15, 2022 Filed Jul 15, 2022 20:11 UTC PurchaseCommon Stock 1,000 $31.76 $31,760.00
Disclosure

SEC source: 0001062993-22-016396 · form4.xml · nonDerivative · entry 1

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,000

F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020.

Read SEC document
July 12, 2022 Filed Jul 13, 2022 20:42 UTC GrantCommon Stock 4,490 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-016309 · form4.xml · nonDerivative · entry 1

Rollins Carissa · CIK 0001916557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,490

F1 · security: Restricted stock grant which vests in one year.

Read SEC document
July 11, 2022 Filed Jul 12, 2022 20:58 UTC
Gomez Tammy LEVP, CHRO
GrantCommon Stock 15,904 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-016270 · form4.xml · nonDerivative · entry 1

Gomez Tammy L · CIK 0001937481 · EVP, CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,904

F1 · security: Restricted stock grant which vests one-third per year over three years.

Read SEC document
July 01, 2022 Filed Jul 5, 2022 21:53 UTC
Jochims Jeffrey TEVP, COO and · President P&HS
SaleCommon Stock 8,000 $31.31 $250,480.00
Disclosure

SEC source: 0001062993-22-015956 · form4.xml · nonDerivative · entry 2

Jochims Jeffrey T · CIK 0001772914 · EVP, COO and · President P&HS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,956

F2 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 11, 2022.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:55 UTC
Pace Nicholas JEVP, General Counsel
GrantCommon Stock 551 $27.18 $14,973.43
Disclosure

SEC source: 0001062993-22-015960 · form4.xml · nonDerivative · entry 1

Pace Nicholas J · CIK 0001497051 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,825

F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:54 UTC
Pesicka Edward ADirector · President & CEO
GrantCommon Stock 551 $27.18 $14,973.43
Disclosure

SEC source: 0001062993-22-015958 · form4.xml · nonDerivative · entry 1

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,283,700

F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).

Read SEC document
June 30, 2022 Filed Jul 5, 2022 21:53 UTC
Jochims Jeffrey TEVP, COO and · President P&HS
GrantCommon Stock 551 $27.18 $14,973.43
Disclosure

SEC source: 0001062993-22-015956 · form4.xml · nonDerivative · entry 1

Jochims Jeffrey T · CIK 0001772914 · EVP, COO and · President P&HS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,956

F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).

Read SEC document
June 01, 2022 Filed Jun 2, 2022 12:42 UTC GrantCommon Stock 4,713 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-014073 · form4.xml · nonDerivative · entry 1

Kline Teresa L. · CIK 0001712647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,713

F1 · security: Restricted stock grant which vests in one year.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 12:41 UTC GrantCommon Stock 4,713 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-014072 · form4.xml · nonDerivative · entry 1

Johnson-Mills Rita · CIK 0001749622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,713

F1 · security: Restricted stock grant which vests in one year.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 12:27 UTC GrantPhantom Stock · Derivative 918 $34.04 $31,248.72
Disclosure

SEC source: 0001062993-22-014246 · form4.xml · derivative · entry 1

MCGETTRICK MARK F · CIK 0001164770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,644

Underlying: Common Stock · 918 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
June 01, 2022 Filed Jun 3, 2022 12:26 UTC GrantPhantom Stock · Derivative 276 $34.04 $9,395.04
Disclosure

SEC source: 0001062993-22-014245 · form4.xml · derivative · entry 1

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,277

Underlying: Common Stock · 276 shares

Expires not disclosed

F1 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F1 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
May 17, 2022 Filed May 18, 2022 20:11 UTC
Pesicka Edward ADirector · President & CEO
SaleCommon Stock 12,028 $35.92 $432,093.87
Disclosure

SEC source: 0001062993-22-012902 · form4.xml · nonDerivative · entry 1

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,283,149

F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022

F2 · price: Weighted average of the sale price range of $35.27 through $36.20

Read SEC document
May 16, 2022 Filed May 17, 2022 20:15 UTC
Pesicka Edward ADirector · President & CEO
Tax withholdingCommon Stock 9,881 $36.05 $356,210.05
Disclosure

SEC source: 0001062993-22-012735 · form4.xml · nonDerivative · entry 5

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,295,177

F6 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 16, 2022 Filed May 17, 2022 20:15 UTC
Pesicka Edward ADirector · President & CEO
SaleCommon Stock 1,100 $36.03 $39,631.90
Disclosure

SEC source: 0001062993-22-012735 · form4.xml · nonDerivative · entry 4

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,305,058

F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022

F5 · price: Weighted average of the sale price range of $35.98 through $36.16

Read SEC document
May 16, 2022 Filed May 17, 2022 20:15 UTC
Pesicka Edward ADirector · President & CEO
SaleCommon Stock 53,875 $35.31 $1,902,110.75
Disclosure

SEC source: 0001062993-22-012735 · form4.xml · nonDerivative · entry 3

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,306,158

F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022

F4 · price: Weighted average of the sale price range of $34.97 through $35.96

Read SEC document
May 16, 2022 Filed May 17, 2022 20:15 UTC
Pesicka Edward ADirector · President & CEO
SaleCommon Stock 1,914 $36.05 $69,003.53
Disclosure

SEC source: 0001062993-22-012735 · form4.xml · nonDerivative · entry 2

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,360,033

F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022

F3 · price: Weighted average of the sale price range of $35.96 through $36.16

Read SEC document
May 16, 2022 Filed May 17, 2022 20:15 UTC
Pesicka Edward ADirector · President & CEO
SaleCommon Stock 75,675 $35.30 $2,671,554.53
Disclosure

SEC source: 0001062993-22-012735 · form4.xml · nonDerivative · entry 1

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,361,947

F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022

F2 · price: Weighted average of the sale price range of $34.96 through $35.95

Read SEC document
May 16, 2022 Filed May 17, 2022 20:13 UTC
Jochims Jeffrey TEVP, Chief Operating Officer · & Pres, PHS
Tax withholdingCommon Stock 4,120 $36.05 $148,526.00
Disclosure

SEC source: 0001062993-22-012733 · form4.xml · nonDerivative · entry 1

Jochims Jeffrey T · CIK 0001772914 · EVP, Chief Operating Officer · & Pres, PHS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,405

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person.

Read SEC document
May 16, 2022 Filed May 17, 2022 20:10 UTC Tax withholdingCommon Stock 4,267 $36.05 $153,825.35
Disclosure

SEC source: 0001062993-22-012729 · form4.xml · nonDerivative · entry 1

Long Andrew G · CIK 0001714880 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,851

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 16, 2022 Filed May 17, 2022 20:12 UTC
Leon Jonathan ASVP, Corporate Treasurer
Tax withholdingCommon Stock 786 $36.05 $28,335.30
Disclosure

SEC source: 0001062993-22-012732 · form4.xml · nonDerivative · entry 2

Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,437

F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 16, 2022 Filed May 17, 2022 20:12 UTC
Leon Jonathan ASVP, Corporate Treasurer
SaleCommon Stock 10,290 $36.80 $378,672.00
Disclosure

SEC source: 0001062993-22-012732 · form4.xml · nonDerivative · entry 1

Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,223

F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 1, 2022

Read SEC document
May 16, 2022 Filed May 17, 2022 20:06 UTC
Lowry Michael WayneSVP, Corporate Controller
Tax withholdingCommon Stock 786 $36.05 $28,335.30
Disclosure

SEC source: 0001062993-22-012723 · form4.xml · nonDerivative · entry 1

Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,351

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 16, 2022 Filed May 17, 2022 20:05 UTC
Pace Nicholas JEVP, General Counsel
Tax withholdingCommon Stock 2,695 $36.05 $97,154.75
Disclosure

SEC source: 0001062993-22-012722 · form4.xml · nonDerivative · entry 1

Pace Nicholas J · CIK 0001497051 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,274

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 12, 2022 Filed May 13, 2022 13:09 UTC SaleCommon Stock 7,600 $35.32 $268,432.00
Disclosure

SEC source: 0001062993-22-012313 · form4.xml · nonDerivative · entry 1

Bingham Gwendolyn M · CIK 0001804960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,184

F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2022.

Read SEC document
May 11, 2022 Filed May 12, 2022 21:19 UTC
Pace Nicholas JEVP, General Counsel
Tax withholdingCommon Stock 7,185 $37.62 $270,299.70
Disclosure

SEC source: 0001062993-22-012287 · form4.xml · nonDerivative · entry 1

Pace Nicholas J · CIK 0001497051 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,969

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 11, 2022 Filed May 12, 2022 21:19 UTC
Pesicka Edward ADirector · President & CEO
Tax withholdingCommon Stock 45,163 $37.62 $1,699,032.06
Disclosure

SEC source: 0001062993-22-012289 · form4.xml · nonDerivative · entry 1

Pesicka Edward A · CIK 0001439487 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,437,622

F1 · price: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 11, 2022 Filed May 12, 2022 21:19 UTC
Lowry Michael WayneSVP, Corporate Controller
Tax withholdingCommon Stock 2,176 $37.62 $81,861.12
Disclosure

SEC source: 0001062993-22-012285 · form4.xml · nonDerivative · entry 1

Lowry Michael Wayne · CIK 0001569290 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,137

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 11, 2022 Filed May 12, 2022 21:18 UTC Tax withholdingCommon Stock 7,185 $37.62 $270,299.70
Disclosure

SEC source: 0001062993-22-012284 · form4.xml · nonDerivative · entry 1

Long Andrew G · CIK 0001714880 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,118

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 11, 2022 Filed May 12, 2022 21:18 UTC
Leon Jonathan ASVP, Corporate Treasurer
Tax withholdingCommon Stock 2,566 $37.62 $96,532.92
Disclosure

SEC source: 0001062993-22-012283 · form4.xml · nonDerivative · entry 1

Leon Jonathan A · CIK 0001740352 · SVP, Corporate Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,513

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

Read SEC document
May 11, 2022 Filed May 12, 2022 21:18 UTC
Jochims Jeffrey TEVP, Chief Operating Officer · & Pres, PHS
Tax withholdingCommon Stock 7,928 $37.62 $298,251.36
Disclosure

SEC source: 0001062993-22-012282 · form4.xml · nonDerivative · entry 1

Jochims Jeffrey T · CIK 0001772914 · EVP, Chief Operating Officer · & Pres, PHS

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,525

F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person.

F2 · balance_after: An adjustment of five shares has been made to the beneficial ownership total to correct an administrative error on April 8, 2022 in reporting the number of common shares returned to the Issuer upon the vesting of restricted stock.

Read SEC document
May 10, 2022 Filed May 11, 2022 20:19 UTC
Starck Daniel JEVP, President Patient Direct · & CEO of Apria
GrantCommon Stock 21,598 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-012099 · form4.xml · nonDerivative · entry 1

Starck Daniel J · CIK 0001345856 · EVP, President Patient Direct · & CEO of Apria

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,598

F1 · security: Restricted stock grant which vests one-third per year over three years.

Read SEC document
May 02, 2022 Filed May 3, 2022 12:31 UTC PurchaseCommon Stock 2,000 $35.00 $70,000.00
Disclosure

SEC source: 0001062993-22-011322 · form4.xml · nonDerivative · entry 1

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,000

F1 · shares: The purchase of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 30, 2020.

Read SEC document
April 29, 2022 Filed May 3, 2022 12:32 UTC GrantCommon Stock 4,931 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011325 · form4.xml · nonDerivative · entry 1

Gardner-Smith Kenneth · CIK 0001914198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,510

F1 · security: Restricted stock with a one-year vesting date

Read SEC document
April 29, 2022 Filed May 3, 2022 12:32 UTC GrantCommon Stock 4,931 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011323 · form4.xml · nonDerivative · entry 1

Bingham Gwendolyn M · CIK 0001804960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,784

F1 · security: Restricted stock with one year vesting date.

Read SEC document
April 29, 2022 Filed May 3, 2022 12:32 UTC GrantCommon Stock 4,931 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011324 · form4.xml · nonDerivative · entry 1

Klemash Stephen W · CIK 0001848495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,639

F1 · security: Restricted stock with one year vesting date.

Read SEC document
April 29, 2022 Filed May 3, 2022 12:31 UTC GrantPhantom Stock · Derivative 4,931 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-011322 · form4.xml · derivative · entry 3

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,001

Underlying: Common Stock · 4,931 shares

Expires not disclosed

F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document
April 29, 2022 Filed May 3, 2022 12:31 UTC GrantPhantom Stock · Derivative 1 $35.49 $35.49
Disclosure

SEC source: 0001062993-22-011322 · form4.xml · derivative · entry 2

Henkel Robert J · CIK 0001789650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,070

Underlying: Common Stock · 1 shares

Expires not disclosed

F2 · derivative.exercise_price: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F3 · shares: Shares acquired through quarterly dividend reinvestment transaction.

F2 · derivative.exercise_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

F2 · derivative.expiration_date: The shares of phantom stock are convertible on a 1-for-1 basis and become payable, in cash or common stock, at the election of the reporting person, upon the occurrence of one of the following (as elected in advance by the reporting person): (a) death, (b) disability, (c) termination of service as director, (d) specified future delivery date, or (e) the earliest to occur of (a), (b), (c) or (d).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.